Spyre Therapeutics
SYRE
#2350
Rank
A$11.44 B
Marketcap
A$129.83
Share price
-0.07%
Change (1 day)
460.25%
Change (1 year)

Quarterly Reports

Thumbnail Spyre Therapeutics Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2024-q3

Quarterly Report 2024-q3

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2024-q2

Quarterly Report 2024-q2

Language: English

View Quarterly Report
Thumbnail Spyre Therapeutics Quarterly Report 2024-q1

Quarterly Report 2024-q1

Language: English

View Quarterly Report